Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances.
Tübingen, Germany. In Curr Opin Endocrinol Diabetes Obes, Feb 2016
PURPOSE OF REVIEW: Glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) are gastrointestinal peptides that play an important role as incretin hormones in the regulation of plasma glucose and insulin secretion.
Pharmacology, physiology, and mechanisms of incretin hormone action.
Toronto, Canada. In Cell Metab, 2013
Incretin peptides, principally GLP-1 and GIP, regulate islet hormone secretion, glucose concentrations, lipid metabolism, gut motility, appetite and body weight, and immune function, providing a scientific basis for utilizing incretin-based therapies in the treatment of type 2 diabetes.